New Horizon Health Limited

HKEX:6606.HK

14.14 (HKD) • At close July 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q22023 Q12022 Q42022 Q32022 Q22020 Q42020 Q32019 Q4
Operating Activities:
Net Income 62.82762.827-6.978-6.978-32.641-254.9360-43.862
Depreciation & Amortization 15.52215.5221.0831.08311.0694.42904.35
Deferred Income Tax 00195.037227.703018.89307.654
Stock Based Compensation 34.10434.10428.61428.6145.755.58401.764
Change In Working Capital 00-258.214-258.2140-8.7550-11.336
Accounts Receivables 00-237.808-237.8080000
Change In Inventory 00-18.509-18.5090-0.2260-0.254
Change In Accounts Payables 00000000
Other Working Capital 00-1.897-1.8970-8.5290-11.082
Other Non Cash Items -285.77-285.77148.271148.271-103.222191.9330-7.177
Operating Cash Flow -173.317-173.317-87.225-87.225-119.044-42.852-29.621-48.607
Investing Activities:
Investments In Property Plant And Equipment -36.221-36.221-15.603-15.603-8.134-10.475-8.631-7.616
Acquisitions Net 0.0400.0040001.0160.921
Purchases Of Investments -896.2990-1,231.655000-136.202-63.653
Sales Maturities Of Investments 742.37801,294.01000.65869.84880.264
Other Investing Activites -64.384-64.38413.5713.57356.1460.588-10.5420.048
Investing Cash Flow -100.605-100.605-2.033-2.033348.013-9.229-84.5119.964
Financing Activities:
Debt Repayment -226.190-112.77100-0.00100
Common Stock Issued 755.63200.7390000.5414.631
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 425.415425.41542.9342.93-5.191-3.049253.40148.407
Financing Cash Flow 425.415425.41542.9342.93-5.191-3.05253.94163.038
Other Information:
Effect Of Forex Changes On Cash 12.37612.37621.79221.79223.037-9-18.742-2.716
Net Change In Cash 402.535163.868-242.401-24.536246.814-64.131121.06721.679
Cash At End Of Period 1,672.772163.8681,270.2371,155.9091,180.445451.796515.927346.434